3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma
3
Triple Negative Breast Neoplasms
2
Glioblastoma
2
Squamous Cell Carcinoma of Head and Neck
1
Pancreatic Neoplasms
1
Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Liver Neoplasms
1
Glioma
1
Fibrolamellar hepatocellular carcinoma
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Nivolumab
5
Ipilimumab
4
Cyclophosphamide
4
pembrolizumab
3
fludarabine phosphate
3
fludarabine
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
2
Interleukin-2
2
trametinib
1
tebentafusp
1
ruxolitinib
1
omipalisib
1
olaparib
1
lifileucel
1
binimetinib
1
belinostat
1
avelumab
1
Vorinostat
1
Valproic Acid
1
Tape Recording
1
Sunitinib
1
Spinal Puncture
1
Radiosurgery
1
Practice Guidelines as Topic
1
Pemetrexed
1
Methods
1
Iodized Oil
1
Interleukin-13
1
Health Promotion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uveal Melanoma
×
poly ICLC
×
90 days
×
Clear all
No trials found.